Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: A pilot study

American Journal of Nephrology

Volumn 24, Issue 5, 2004, Pages 469-473

  Katopodis, Konstantinos P ^a   Elisaf, Moses ^a   Balafa, Olga ^a   Nikolopoulos, Petros ^a   Bairaktari, Eleni ^b   Katsaraki, Afroditi ^a   Siamopoulos, Kostas C ^a,c  

^a Department of Nephrology ^*  (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Hemodialysis; Heparin; Lipids; Membranes

Indexed keywords

ALBUMIN; ETHYLENE VINYL ALCOHOL COPOLYMER; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW MOLECULAR WEIGHT HEPARIN; POLYACRYLONITRILE; PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; FEMALE; HEMOCONCENTRATION; HUMAN; LIPID BLOOD LEVEL; MALE; MEASUREMENT; MEMBRANE; MOLECULAR WEIGHT; PARAMETER; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; LIPIDS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PILOT PROJECTS; RENAL DIALYSIS;

EID: 10644272407     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080591     Document Type: Article

References (10)

1. Attman PO, Samuelsson O, Alaupovic P: Lipoprotein metabolism in renal failure. Am J Kidney Dis 1993;21:573-592.
2. Arnadottir M, Kurkus J, Nilson-Ehle P: Different types of heparin in hemodialysis: Longterm effects on post-heparin lipases. Scand J Clin Lab Invest 1994;54:515-521.
3. Blankestijn PJ, Rabelink TJ, Koomas HA, van Rijn HJM, Vos PF, Jansen H: High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 1995;5:1703-1708.
4. Tzanatos H, Fourtounas C, Agroyannis B, Chondros K, Dalamangas A, Bossiolis B, Kopelias I, Koutsikos D: Alterations of plasma lipoprotein (a) concentration. Do they arise from the haemodialysis procedure? Nephrol Dial Transplant 1996;11:1490-1491.
5. Schumacher M, Kebler A, Bahlmann G, Wood WG: Acute changes in concentrations of apolipoproteins A-I, B, C-II and lipoprotein (a) in serum covering the period from directly before to 48 hours after chronic haemodialysis. Eur J Clin Chem Clin Biochem 1994;32:123-125.
6. Seres DS, Strain GW, Hasmin SA, Goldberg IJ, Levin NW: Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 1993;3:1409-1415.
7. Bergstrom J, Wehle B: No change in corrected beta 2-microglobulin concentration after cuprophan hemodialysis. Lancet 1987;i:628-629.
8. Mol MJ, Demacker PN, Stalenhoef AF: The role of modification of lipoproteins and of the immune system in early atherogenesis. N Engl J Med 1993;43:83-90.
9. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M: Transient changes of serum lipoprotein (a) as an acute phase protein. Atherosclerosis 1989;78:145-150.
10. Levine DM, Gordon BR: Lipoprotein (a) levels in patients receiving renal replacement therapy: Methodologic issues and clinical implications. Am J Kidney Dis 1995;26:162-169.